Koers Pure Global Cannabis Inc. Toronto S.E.
Aandelen
PURE.H
CA74625A1075
Farmaceutische producten
Omzet 2017 | - | Omzet 2018 | - | Marktkapitalisatie | 24,16 mln. 32,89 mln. 22,22 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | - 0 0 | Nettowinst (verlies) 2018 | -23 mln. -31,31 mln. -21,15 mln. | EV/omzet 2017 * | - |
Nettoschuld 2017 | 211K 287K 194K | Nettoschuld 2018 | 4,49 mln. 6,11 mln. 4,13 mln. | EV/omzet 2018 | - |
K/w-verhouding 2017 * |
-
| K/w-verhouding 2018 |
-0,72
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 83,64% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Vik Chopra
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sanjeev Goel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Lavergne
PRN | Corporate Officer/Principal | - | 30-07-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jane E. Pagel
BRD | Director/Board Member | - | 01-07-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+42,64% | 6,38 mld. | |
-15,52% | 4,59 mld. | |
+8,35% | 3,39 mld. | |
-11,10% | 3,2 mld. | |
-4,12% | 2,52 mld. | |
+46,46% | 2 mld. | |
-7,97% | 1,7 mld. | |
-1,07% | 1,65 mld. | |
-11,56% | 1,58 mld. |